dopamine D3 partial agonists (Parke Davis)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug Namedopamine D3 partial agonists (Parke Davis)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D3 receptor agonists
TargetsDopamine D3 receptor
Therapy Area/IndicationsMental Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesParke-Davis Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesParke-Davis Corp
Active IndicationsN/A
Inactive IndicationsMental Disorders

Other Information

ATC CodeN/A
Related LinksN/A